City State Bank’s GSK GSK Stock Holding History

City State Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.8K	Hold	606	–	–	0.01%	420
2026 Q1	$33.4K	Hold	606	–	–	0.01%	401
2025 Q4	$29.7K	Hold	606	–	–	0.01%	416
2025 Q3	$26.2K	Hold	606	–	–	0.01%	420
2025 Q2	$23.3K	Hold	606	–	–	0.01%	424
2025 Q1	$23.5K	Hold	606	–	–	0.01%	424
2024 Q4	$20.5K	Sell	606 -180	-23%	-$6.48K	0.01%	422
2024 Q3	$32.1K	Hold	786	–	–	0.01%	377
2024 Q2	$30.3K	Sell	786 -5,713	-88%	-$240K	0.01%	375
2024 Q1	$279K	Buy	6,499 +632	+11%	+$26.1K	0.12%	148
2023 Q4	$217K	Sell	5,867 -425	-7%	-$15.3K	0.11%	163
2023 Q3	$228K	Sell	6,292 -492	-7%	-$17.5K	0.13%	154
2023 Q2	$242K	Sell	6,784 -40	-0.6%	-$1.44K	0.13%	153
2023 Q1	$243K	Buy	6,824 +232	+4%	+$8.12K	0.14%	149
2022 Q4	$232K	Buy	+6,592	New	+$220K	0.14%	151
2022 Q3	–	Sell	-7,776	Closed	-$423K	–	679
2022 Q2	$423K	Sell	7,776 -7	-0.1%	-$386	0.29%	89
2022 Q1	$424K	Buy	7,783 +400	+5%	+$21.7K	0.26%	101
2021 Q4	$407K	Buy	+7,383	New	+$384K	0.25%	103

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

City State Bank's GSK Position: Q2 2026 in Review

City State Bank held its GSK (GSK) position steady in Q2 2026 at 606 shares worth $31.8K. The position accounts for 0.01% of the portfolio, ranked #420.

City State Bank first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $424K in Q1 2022. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

City State Bank held 606 shares of GSK worth $31.8K as of Q2 2026.
City State Bank left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of City State Bank's portfolio in Q2 2026, its #420 holding.
City State Bank first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
City State Bank's GSK position peaked at $424K in Q1 2022.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.